Longitudinal changes of benign prostate-specific antigen and [-2]proprostate-specific antigen in seven years in a community-based sample of men

Urology

Volumn 79, Issue 3, 2012, Pages 655-661

  Rhodes, Thomas ^a,b   Jacobson, Debra J ^c   McGree, Michaela E ^c   St Sauver, Jennifer L ^c   Girman, Cynthia J ^b   Lieber, Michael M ^c   Klee, George G ^c   Demissie, Kitaw ^a   Jacobsen, Steven J ^d  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Mayo Clinic   (United States)

^d KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENIGN PROSTATE SPECIFIC ANTIGEN; PROPROSTATE SPECIFIC ANTIGEN; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL EXAMINATION; FOLLOW UP; FROZEN SECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY;

EID: 84857863787     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2011.09.056     Document Type: Article

References (30)

1. J.E. Oesterling, S.J. Jacobsen, C.G. Chute Serum prostate-specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges JAMA 270 1993 860 864 (Pubitemid 23234116)
2. W.J. Catalona, P.C. Southwick, K.M. Slawin Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging Urology 56 2000 255 260 (Pubitemid 30495578)
3. S.D. Mikolajczyk, L.S. Millar, T.J. Wang "BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia Urology 55 2000 41 45 (Pubitemid 30050755)
4. E.I. Canto, H. Singh, S.F. Shariat Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer Urology 63 2004 905 911
5. W.J. Catalona, G. Bartsch, H.G. Rittenhouse Serum pro prostate specific antigen improves cancer detection compared to free and complexed prostate specific antigen in men with prostate specific antigen 2 to 4 ng/ml J Urol 170 2003 2181 2185 (Pubitemid 37413952)
6. D.V. Makarov, S. Isharwal, L.J. Sokoll Proprostate-specific antigen measurements in serum and tissue are associated with treatment necessity among men enrolled in expectant management for prostate cancer Clin Cancer Res 15 2009 7316 7321
7. B.V. Le, C.R. Griffin, S. Loeb [-2]Proenzyme prostate specific antigen is more accurate than total and free prostate specific antigen in differentiating prostate cancer from benign disease in a prospective prostate cancer screening study J Urol 183 2010 1355 1359
8. W.J. Catalona, A.W. Partin, M.G. Sanda A multicenter study of [-2]proprostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range J Urol 185 2011 1650 1655
9. L.J. Sokoll, M.G. Sanda, Z. Feng A prospective, multicenter, National Cancer Institute early detection research network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness Cancer Epidemiol Biomarkers Prev 19 2010 1193 1200
10. T. Rhodes, D.J. Jacobson, M.E. McGree Benign prostate-specific antigen distributions and associations with urologic outcomes in community-dwelling black and white men J Urol 187 1 2012 87 91
11. T. Rhodes, D.J. Jacobson, M.E. McGree Distribution and associations of [-2]proprostate-specific antigen in community-dwelling black and white men J Urol 187 1 2012 92 96
12. C.G. Roehrborn, J.D. McConnell, B. Saltzman Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes Eur Urol 42 2002 1 6 (Pubitemid 35339638)
13. E.D. Crawford, S.S. Wilson, J.D. McConnell Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo J Urol 175 2006 1422 1427
14. S.J. Jacobsen, D.J. Jacobson, C.J. Girman Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status J Urol 162 1999 1301 1306 (Pubitemid 29428567)
15. H.B. Carter, J.D. Pearson, E.J. Metter Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease JAMA 267 1992 2215 2220
16. C.G. Chute, L.A. Panser, C.J. Girman The prevalence of prostatism: a population-based survey of urinary symptoms J Urol 150 1993 85 89 (Pubitemid 23175978)
17. S.J. Jacobsen, H.A. Guess, L. Panser A population-based study of health care-seeking behavior for treatment of urinary symptoms: the Olmsted County study of urinary symptoms and health status among men Arch Fam Med 2 1993 729 735
18. M.J. Barry, F.J. Fowler Jr, M.P. O'Leary The American Urological Association symptom index for benign prostatic hyperplasia: the Measurement Committee of the American Urological Association J Urol 148 1992 1549 1557 1564
19. T. Rhodes, C.J. Girman, S.J. Jacobsen Longitudinal prostate growth rates during 5 years in randomly selected community men 40 to 79 years old J Urol 161 1999 1174 1179 (Pubitemid 29426112)
20. M.K. Terris, T.A. Stamey Determination of prostate volume by transrectal ultrasound J Urol 145 1991 984 987
21. S.J. Jacobsen, D.J. Jacobson, C.J. Girman Natural history of prostatism: risk factors for acute urinary retention J Urol 158 1997 481 487 (Pubitemid 27327692)
22. N.M. Laird, J.H. Ware Random-effects models for longitudinal data Biometrics 38 1982 963 974
23. H.A. Feldman Families of lines: random effects in linear regression analysis J Appl Physiol 64 1988 1721 1732
24. J.L. St. Sauver, D.J. Jacobson, C.J. Girman Tracking of longitudinal changes in measures of benign prostatic hyperplasia in a population based cohort J Urol 175 2006 1018 1022 (Pubitemid 43200061)
25. J.L. St. Sauver, D.J. Jacobson, C.J. Girman Correlations between longitudinal changes in transitional zone volume and measures of benign prostatic hyperplasia in a population-based cohort Eur Urol 50 2006 105 111 (Pubitemid 43850112)
26. M.M. Lieber, T. Rhodes, D.J. Jacobson Natural history of benign prostatic enlargement: long-term longitudinal population-based study of prostate volume doubling times BJU Int 105 2010 214 219
27. T.Y. Chan, S.D. Mikolajczyk, K. Lecksell Immunohistochemical staining of prostate cancer with monoclonal antibodies to the precursor of prostate-specific antigen Urology 62 2003 177 181 (Pubitemid 36802110)
28. C. Stephan, A.M. Kahrs, H. Cammann A [-2]proPSA-based artificial neural network significantly improves differentiation between prostate cancer and benign prostatic diseases Prostate 69 2009 198 207
29. N.M. Gades, D.J. Jacobson, M.E. McGree Dropout in a longitudinal, cohort study of urologic disease in community men BMC Med Res Methodol 6 2006 58
30. B. Djavan Validity and legacy of prostate-specific antigen (PSA) and PSA-based parameters and isoforms in the new millennium Eur Urol 57 2010 928 929